COL6A3 and breast cancer: Recently, we identified endotrophin, a cleavage product of COL6A3 that is actively involved in mammary tumour progression through enhancing the epithelial–mesenchymal transition (EMT), fibrosis and chemokine activity, thereby recruiting stromal cells to the tumour microenvironment (Park & Scherer, 2012a, b).